These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8302603

  • 1. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor).
    Longati P, Bardelli A, Ponzetto C, Naldini L, Comoglio PM.
    Oncogene; 1994 Jan; 9(1):49-57. PubMed ID: 8302603
    [Abstract] [Full Text] [Related]

  • 2. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM.
    EXS; 1993 Jan; 65():131-65. PubMed ID: 8380735
    [Abstract] [Full Text] [Related]

  • 3. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA, Park M.
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [Abstract] [Full Text] [Related]

  • 4. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
    Fixman ED, Naujokas MA, Rodrigues GA, Moran MF, Park M.
    Oncogene; 1995 Jan 19; 10(2):237-49. PubMed ID: 7838524
    [Abstract] [Full Text] [Related]

  • 5. Structural and functional domains critical for constitutive activation of the HGF-receptor (Met).
    Zhen Z, Giordano S, Longati P, Medico E, Campiglio M, Comoglio PM.
    Oncogene; 1994 Jun 19; 9(6):1691-7. PubMed ID: 8183564
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 19; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 7. Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
    Kamikura DM, Naujokas MA, Park M.
    Biochemistry; 1996 Jan 23; 35(3):1010-7. PubMed ID: 8547236
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.
    Vigna E, Naldini L, Tamagnone L, Longati P, Bardelli A, Maina F, Ponzetto C, Comoglio PM.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul 23; 40(5):597-604. PubMed ID: 7981617
    [Abstract] [Full Text] [Related]

  • 9. The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines.
    Helin K, Velu T, Martin P, Vass WC, Allevato G, Lowy DR, Beguinot L.
    Oncogene; 1991 May 23; 6(5):825-32. PubMed ID: 1646987
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.
    Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM.
    Oncogene; 1991 Apr 23; 6(4):501-4. PubMed ID: 1827664
    [Abstract] [Full Text] [Related]

  • 11. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B.
    Cell Growth Differ; 1996 Feb 23; 7(2):263-70. PubMed ID: 8822210
    [Abstract] [Full Text] [Related]

  • 12. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G.
    Oncogene; 1991 Dec 23; 6(12):2237-41. PubMed ID: 1837350
    [Abstract] [Full Text] [Related]

  • 13. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase.
    Ferracini R, Longati P, Naldini L, Vigna E, Comoglio PM.
    J Biol Chem; 1991 Oct 15; 266(29):19558-64. PubMed ID: 1655790
    [Abstract] [Full Text] [Related]

  • 14. The hepatocyte growth factor and its receptor.
    Galimi F, Brizzi MF, Comoglio PM.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():22-30. PubMed ID: 8401259
    [Abstract] [Full Text] [Related]

  • 15. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Jul 15; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.
    Oncogene; 2002 Apr 04; 21(15):2309-19. PubMed ID: 11948414
    [Abstract] [Full Text] [Related]

  • 17. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 18. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
    Presnell SC, Stolz DB, Mars WM, Jo M, Michalopoulos GK, Strom SC.
    Mol Carcinog; 1997 Apr 15; 18(4):244-55. PubMed ID: 9142219
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 20. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
    Michieli P, Basilico C, Pennacchietti S, Maffè A, Tamagnone L, Giordano S, Bardelli A, Comoglio PM.
    Oncogene; 1999 Sep 16; 18(37):5221-31. PubMed ID: 10498872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.